Search results for “OX40 Receptors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 130 patents, we discovered top 17 key players by total patent application. Agenus, Inc., Pfizer Inc., Bristol Myers Squibb Co. are dominant in this area. They take 93.08% of the total patent filing.
Agenus, Inc.
Massachusetts, United States
Patent: 39
Pfizer Inc.
New York, United States
Patent: 36
Bristol Myers Squibb Co.
New York, United States
Patent: 33
Genentech, Inc.
California, United States
Patent: 23
Merck Serono SA
Vaud, Switzerland
Patent: 9
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 6
Apogenix AG
Baden-Württemberg, Germany
Patent: 4
YBiologics, Inc.
South Korea
Patent: 3
Sorrento Therapeutics, Inc.
California, United States
Patent: 2
Medarex, Inc.
New Jersey, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 29 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Memorial Sloan Kettering Cancer Center, Ludwig Institute for Cancer Research Ltd., Agenus, Inc. take 141.38% of patent filing during this period.
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 14
Ludwig Institute for Cancer Research Ltd.
New York, United States
Patent: 14
Agenus, Inc.
Massachusetts, United States
Patent: 13
Pfizer Inc.
New York, United States
Patent: 4
Bristol Myers Squibb Co.
New York, United States
Patent: 4
YBiologics, Inc.
South Korea
Patent: 3
Imbiologics Corp.
South Korea
Patent: 2
Sorrento Therapeutics, Inc.
California, United States
Patent: 2
Apogenix AG
Baden-Württemberg, Germany
Patent: 1
The Board of Regents of The University of Texas System
Texas, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 29 patents in last 5 years, we discover 5 new entrants. YBiologics, Inc., Imbiologics Corp., Sorrento Therapeutics, Inc. are the most active new entrants in this area.
YBiologics, Inc.
South Korea
Patent: 3
Imbiologics Corp.
South Korea
Patent: 2
Sorrento Therapeutics, Inc.
California, United States
Patent: 2
BeiGene Ltd.
Massachusetts, United States
Patent: 1
Dongda Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 92 patents, we discovered top 1 universities and scientific research institutions by total patent application.
Duke University
North Carolina, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: